Takeda Pharmaceutical Co Ltd
SWB:TKDA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Takeda Pharmaceutical Co Ltd
SWB:TKDA
|
JP |
|
C
|
China Lilang Ltd
F:5LX
|
CN |
|
A
|
Adidas AG
MIL:ADS
|
DE |
|
B
|
Brunello Cucinelli SpA
XMUN:8BU
|
IT |
|
L
|
Liveramp Holdings Inc
SWB:XIM
|
US |
|
T
|
Thai Stanley Electric PCL
SET:STANLY
|
TH |
|
Guangdong Investment Ltd
HKEX:270
|
HK |
|
Essential Utilities Inc
NYSE:WTRG
|
US |
|
Cohen & Steers Inc
NYSE:CNS
|
US |
|
B
|
Bank CIMB Niaga Tbk PT
XMUN:NKX
|
ID |
Wall St Price Targets
TKDA Price Targets Summary
Takeda Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for TKDA is 17.29 EUR with a low forecast of 14.37 EUR and a high forecast of 22.7 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TKDA's stock price target?
Price Target
17.29
EUR
According to Wall Street analysts, the average 1-year price target for TKDA is 17.29 EUR with a low forecast of 14.37 EUR and a high forecast of 22.7 EUR.
What is the Revenue forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 3%.
What is the Gross Profit forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 2 years is 2%.
What is the Operating Income forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
-24%
Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 1 year is -24%.
